How effective is Rasuvo for Psoriatic Arthritis? (a real world drug study)
Summary:
Overall ratings: 2.9/5 Long term ratings: 3/5
This is a phase IV clinical study of how effective Rasuvo (methotrexate) is for Psoriatic arthritis and for what kind of people. The study is created by eHealthMe from 10 Rasuvo users and is updated continuously.
What is Rasuvo?
Rasuvo has active ingredients of methotrexate. It is often used in psoriatic arthritis. eHealthMe is studying from 3,702 Rasuvo users. Check the latest studies of Rasuvo.
What is Psoriatic arthritis?
Psoriatic arthritis: no further information found. Check the latest studies of Psoriatic arthritis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
10 people are studied for taking Rasuvo in Psoriatic arthritis
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Rasuvo effectiveness for Psoriatic arthritis (number of people):
Overall:
- not at all: 0
- somewhat: 5
- moderate: 2
- high: 2
- very high: 1
Long Term:
- not at all: 0
- somewhat: 4
- moderate: 1
- high: 2
- very high: 1
Gender of people who take Rasuvo for Psoriatic arthritis *:
- female: 80 %
- male: 20 %
Age of people who take Rasuvo for Psoriatic arthritis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 10 %
- 40-49: 20 %
- 50-59: 30 %
- 60+: 40 %
Who find Rasuvo more effective for Psoriatic Arthritis?
Gender of people who take Rasuvo for Psoriatic arthritis *:
- female: 100 %
- male: 0.0 %
Age of people who take Rasuvo for Psoriatic arthritis *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 66.67 %
- 50-59: 33.33 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Rasuvo?
- You can start a phase IV clinical trial to monitor Rasuvo safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Guidelli GM, Tenti S, Fioravanti A, "Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis", Indian Journal of Dermatology, Venereology, and Leprology, 2015 Jan .
- Guidelli GM, Tenti S, Fioravanti A, "Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis", Indian Journal of Dermatology, Venereology, and Leprology, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Rasuvo (3,702 reports)
Treatments, associated drugs and conditions:
- Psoriatic arthritis (1,740 reports)
How the study uses the data?
The study is based on methotrexate (the active ingredients of Rasuvo) and Rasuvo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Famotidine for Indigestion? - a second ago
- Could Pantoprazole cause Hot Flush? - 4 seconds ago
- Drug interactions of Aranesp and Zosyn - 6 seconds ago
- How effective is Lovastatin for High Blood Pressure? - 9 seconds ago
- Dyskinesia and drugs of ingredients of stiripentol - 9 seconds ago
- Common Peroneal Nerve Dysfunction and drugs of ingredients of ondansetron hydrochloride - 10 seconds ago
- Septic Embolus and drugs of ingredients of tramadol hydrochloride - 13 seconds ago
- Multiple Myeloma and Failure To Thrive - 21 seconds ago
- Could Profen cause Secondary Progressive Multiple Sclerosis? - 22 seconds ago
- Gait Disturbance and drugs of ingredients of krill oil - 22 seconds ago